Dr Nathan MULURE Profile
Dr Nathan MULURE

@MulureNathan

Followers
358
Following
1K
Media
19
Statuses
535

Global Health. Public Affairs. Opinions own.

Nairobi, Kenya
Joined September 2014
Don't wanna be here? Send us removal request.
@BrownJHM
Journal of Brown Hospital Medicine
3 years
7
110
509
@AfremeEngage
AFRÉME
3 years
, Representatives from the French Embassy - Bernard Clouteau and Laurence Mondesir and AFRÉME founder @MulureNathan and AFRÉME members.
0
1
2
@ppbkenya
Pharmacy and Poisons
3 years
Two imposters masquerading as @ppbkenya inspectors have finally been nabbed at Nyangoma area of Siaya County. Kudos to members of the public who assisted in the arrest of the duo after PBB sounded an alert notice of the imposters on social media.
1
17
25
@bello_yves
Pierre-Yves Bello
3 years
Une poursuite de l'engagement structurant de la France aux côtés du Fonds Mondial et d'UNITAID. Bonne nouvelle !
@EmmanuelMacron
Emmanuel Macron
3 years
Nous devons tenir notre promesse pour 2030 : le sida, le paludisme et la tuberculose devront avoir disparu. https://t.co/lPmfrdfZ8J
0
1
7
@Kemsa_Kenya
KEMSA
4 years
The Kenya Medical Supplies Authority (KEMSA) has pledged to support the health promotion agenda at the county level for newly elected Governors as part of the Authority's three-pronged transformation strategy. #HereToServe #KEMSADelivers
3
26
115
@UNITAID
Unitaid
4 years
The impact of @UNITAID's work reaches more than 100 million people each year with health advances that transform the quality of care for some of the most pressing global health challenges including #HIV #tuberculosis #malaria and #COVID19. #UnitaidAt15
0
3
3
@RoshiniGeorge2
Roshini George
4 years
Delighted to see the launch of Ghana’s national NCD policy and strategy @WHO @GhanaMoh @PATH
0
5
17
@bello_yves
Pierre-Yves Bello
4 years
Yesterday, courtesy call to Dr Seif Shakalaghe, Deputy PS @wizara_afyatz prior to a whole day of meetings with programmes of the MoH. Thanks to all for the warm welcome and constructive discussion. Through @GlobalFund, @GAVI and @UNITAID 🇫🇷 is a big supporter of health in 🇹🇿.
1
2
9
@MulureNathan
Dr Nathan MULURE
4 years
Great meeting with French Embassy officials to discuss Kenya 🇰🇪 France 🇫🇷 collaboration in medical education. Opportunities for post graduate studies in France for Kenyan doctors. Many Thanks to AFREME members, Nikita et al, Dr Mathieu and Dr Bello. @FranceinKenya
1
3
18
@IFPMA
IFPMA
4 years
As an #AMATA member, @IFPMA is happy to see 30 African countries backing the #AfricanMedicinesAgency. Endorsement of the entire continent is needed for the AMA to deliver on its mandate effectively! ⬆️Access to💊 ⬆️Local production💉 ⬇️Fake meds https://t.co/IACcwtLV20 #EABF
1
1
4
@jeremieblin
Jérémie BLIN
4 years
Heureux de cette nouvelle rencontré avec Dr Sylvie Nzeyimana, Ministre @mspls_bdi, pour ces échanges sur l'action de la France dans la santé et sur le projet de @AFD_France qui appuiera le CNTS et @insp_burundi et renforcera la formation de professionnels de la santé.
@msp_burundi
Ministère de la Santé Publique Burundi(MSP)
4 years
Le Ministre a reçu enfin une délégation de l’Agence Française pour le Développement (AFD) conduite par Jérémie Blin, l’Ambassadeur de France au Burundi.
0
5
13
@laktarr001
𝔻𝕣. 𝔸𝕙𝕞𝕖𝕕 𝕆𝕘𝕨𝕖𝕝𝕝 - 𝔽𝔸ℙℍ
4 years
Come join us at @AfricaCDC as we mark our 5th anniversary. Five busy, hectic, rewarding years Safeguarding Africa’s Health. #AfricaCDCat5 #NewPublicHealthOrder #AfricaResponds @_AfricanUnion
1
5
35
@naokoy21
Naoko Yamamoto
4 years
At EB of WHO, we discuss broad agendas of NCD, including an implementation road map of NCD, diabetes responses, oral health, obesity, mental health and an Action Plan to reduce harmful use of alcohol. Resilient health systems are keys to continue and improve NCD services .
3
16
85
@muhimbiliuniver
Muhimbili University
4 years
Sickle Cell Disease Dissemination Symposium, MUHAS Wed, Jan 26, 2022 12:30 PM East Africa Time Link https://t.co/DCFxZ0TLDd Meeting ID: 880 4421 2215 Passcode: 734208
0
19
58
@IFPMA
IFPMA
4 years
Innovation in #diabetes treatment & care gives us hope for the future. @IFPMA Ann-Lise highlights her #MissionPossible: improving access to a comprehensive, affordable & quality care for people living with diabetes in lower-resource settings. @EFPIA #WeWontRest
0
4
9
@DavidReddyIFPMA
David Reddy
4 years
The @WHO’s 150th Executive Board session begins today, where they will set the agenda for the World Health Assembly. Let's make sure that eradicating malaria remains a priority. #EndMalaria
1
14
38
@PTMcGann
Pat McGann, MD
4 years
When you assess #SickleCell pain, the only number that matters is the patient’s pain rating. Not the heart rate, not the blood pressure, not the respiratory rate. Not the hemoglobin, fetal hemoglobin, or reticulocyte count. #BelievethePatient Listen, and treat the pain.
24
202
669
@IFPMA
IFPMA
4 years
From investing in new vaccines💉, addressing access barriers, and supporting the appropriate use of #antibiotics💊, the biopharmaceutial industry is working to #beatAMR & to maximize the impact of vaccination on #AntimicrobialResistance (AMR).
0
7
7
@Novartis
Novartis
4 years
“This is first data we have clinically showing that the medicine is able to reduce viral load, potentially speed up recovery time and have a 79% reduction in hospitalizations.” Exciting new Covid-19 treatment discussed on @CNBC with @megtirrell #JPMHC22 $NVS $NOVN
@SquawkStreet
Squawk on the Street
4 years
"This can target the covid spike protein in three different locations and be able to neutralize all the Covid virus strains of concerns pretty consistently." $NVS CEO Vasant Narasimhan joins @megtirrell to discuss their new Covid-19 treatment licensed from $MOLN @CNBC
1
8
32
@NovartisGH
Novartis Global Health
4 years
This new potential treatment for #COVID19 patients provides risk reduction in hospitalizations and/or ER visits or death. We are quite encouraged by the topline data and look forward to our collaboration with @MolecularPrtnrs.
@NovartisNews
Novartis News
4 years
Today, with @MolecularPrtnrs, we are excited to announce a positive top line data from a Phase 2 study for a #COVID19 antiviral treatment. Novartis will exercise its option to in-license this therapeutic candidate from Molecular Partners.  #NovartisNews
0
2
9